Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Beglinger

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2004
Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tractChristian Zimmermann, Heike Gutmann, Petr Hruz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfortEmanuel Burri, Michael Manz, Claude Rothen, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 16, 2016
Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adultsMélanie Wilbaux, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, et al.
Inflammatory Bowel Diseases|May 23, 2009
Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytesAlain M Schoepfer, Christoph Beglinger, Alex Straumann, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndromeMichael Fried, Christoph Beglinger, Nicole Gilgen Bobalj, et al.
Nutrients|March 13, 2024
Metabolic Effects of Selected Conventional and Alternative Sweeteners: A Narrative ReviewFabienne Teysseire, Valentine Bordier, Christoph Beglinger, et al.
Gastrointestinal Endoscopy|March 4, 2003
Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?Alex Straumann, Livio Rossi, Hans-Uwe Simon, et al.
Digestion|December 1, 2006
Effects of a preload on reduction of food intake by GLP-1 in healthy subjectsLukas Degen, Sibylle Oesch, Daniel Matzinger, et al.
Endocrine|April 25, 2012
Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I studyChristoph Beglinger, Ke Hu, Ying Wang, et al.
The British Journal of Nutrition|September 19, 2015
Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetiteLouise Clamp, Anthony P J Hehir, Estelle V Lambert, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2004
Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tractChristian Zimmermann, Heike Gutmann, Petr Hruz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfortEmanuel Burri, Michael Manz, Claude Rothen, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 16, 2016
Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adultsMélanie Wilbaux, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, et al.
Inflammatory Bowel Diseases|May 23, 2009
Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytesAlain M Schoepfer, Christoph Beglinger, Alex Straumann, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndromeMichael Fried, Christoph Beglinger, Nicole Gilgen Bobalj, et al.
Nutrients|March 13, 2024
Metabolic Effects of Selected Conventional and Alternative Sweeteners: A Narrative ReviewFabienne Teysseire, Valentine Bordier, Christoph Beglinger, et al.
Gastrointestinal Endoscopy|March 4, 2003
Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?Alex Straumann, Livio Rossi, Hans-Uwe Simon, et al.
Digestion|December 1, 2006
Effects of a preload on reduction of food intake by GLP-1 in healthy subjectsLukas Degen, Sibylle Oesch, Daniel Matzinger, et al.
Endocrine|April 25, 2012
Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I studyChristoph Beglinger, Ke Hu, Ying Wang, et al.
The British Journal of Nutrition|September 19, 2015
Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetiteLouise Clamp, Anthony P J Hehir, Estelle V Lambert, et al.
Pageof 19